Evidence & policy library
Every pathway is linked to the organizations responsible for the decision.
38 source records
Methodology
Pathway information draws on official regulator, HTA and payer materials. Consult the cited policy for its conditions and effective date, and see Content & use for guidance on applying Atlas to your research.
Matching documents: 42
Market / scopeOfficial evidence recordTypePolicy / reference dateLast checked
APAC
🇦🇺 AustraliaOfficialSelected standard phases and priority determination, clock and exit conditions; standard overview2021 and priority page2024 updates are distinct.2010-02-01Latest observed: 2024-11-12
🇦🇺 AustraliaOfficialSelected standard phases and priority determination, clock and exit conditions; standard overview2021 and priority page2024 updates are distinct.2010-02-01Latest observed: 2024-11-12
🇦🇺 AustraliaOfficialSelected standard phases and priority determination, clock and exit conditions; standard overview2021 and priority page2024 updates are distinct.2010-02-01Latest observed: 2024-11-12
🇦🇺 AustraliaOfficialsubmission structure and decision factorsversion 5.0Latest observed: 2016-09
🇦🇺 AustraliaOfficialpost-PBAC pricing and listingcurrent guidanceLatest observed: checked live
🇦🇺 AustraliaOfficialSPA, caps, shared deeds, renewalguidanceLatest observed: 2017-11-15
🇦🇺 AustraliaOfficialindication-specific/weighted pricingofficial fact sheetLatest observed: checked live
🇦🇺 AustraliaOfficialMES eligibility, evidence, deedeffective 2011-01-01Latest observed: checked live
🇦🇺 AustraliaOfficialSeparate anniversary and first-new-brand discretion timetables; standard HPP applications and new-presentation requestscurrent rules; next reduction day 2027-04-01Latest observed: 2026-08-12
🇦🇺 AustraliaOfficialFNB trigger and F1/F2 transitioncurrent rulesLatest observed: 2026-04-01
🇦🇺 AustraliaOfficialWADP and F2 disclosurecurrent rulesLatest observed: 2025-08-22
🇦🇺 AustraliaOfficialcycle timing reference2025–2027 cyclesLatest observed: 2026-03-24
🇦🇺 AustraliaOfficialpublic/private/community supplycurrent programLatest observed: 2024-04-17
🇦🇺 AustraliaOfficialCurrent NSW governance, inpatient/outpatient supply, transfer and charging policy; product and programme conditions remain separate.2026-08Latest observed: 2026-08
AU-S12 · NSW Health · Medicines Governance in NSW Health Services (PD2026_037)
Read on Atlas · PDFOfficial source ↗Saved copy: © State of New South Wales NSW Ministry of Health. For current information go to www.health.nsw.gov.au. CC BY 4.0
🇦🇺 AustraliaOfficialPublic entry to the current platform and static snapshot; no claim that every formulary row or live clinical stock is checked.Version-specificLatest observed: Date not stated
🇦🇺 AustraliaOfficialConsolidated provisions for presentation and combination pricing, price disclosure, designated brands, discounting and stockholding. The compilation date is not a universal commencement date; individual determinations and product-specific conditions remain relevant.2026-09-19Latest observed: 2026-09-19
🇦🇺 AustraliaOfficialApplication, viability evidence and outcome process; printed timetables and annex extracts are read with current PBS instructions and law.Version date not establishedLatest observed: Current linked guidance; historical annexes
🇦🇺 AustraliaOfficialRecognition, listing and discretion process; historical legislative and agreement annexes do not establish current rates or universal relief rules.Version date not establishedLatest observed: Current linked guidance; historical annexes
🇦🇺 AustraliaOfficialWhole current-linked form, including new-presentation evidence and editable Word return. Older generic route and fee-notice text is not substituted for current service instructions.Version date not establishedLatest observed: Current linked form
🇦🇺 AustraliaOfficialDesignated brands, saleable stock, usual-demand calculations, rebranding/delisting, another quantity, separate disclosure/notification and compliance. Version3 last reviewed3August2026; individual brand determinations remain separate.2026-08-03Latest observed: 2026-08-03
🇦🇺 AustraliaOfficialCurrent designated-brand scope, biannual disclosure, PDSN breach notices, legacy updates and another-quantity application route. Page update31August2026 is distinct from the July2023 statutory start.2023-07-01Latest observed: 2026-08-31
🇦🇺 AustraliaOfficialPrescription and electronic-chart requirements, supply and safety-net rules, price disclosure and stockholding. Compilation and registration dates do not replace provision-specific commencement or product conditions.2026-08-15Latest observed: 2026-08-24
🇦🇺 AustraliaOfficialCurrent fee year, list-management charges, payment and relief instructions. The standalone independent-review amount requires confirmation against the current statutory Category 2 reference.Fee year 2026-07-01 to 2027-06-30Latest observed: 2026-09-21
🇦🇺 AustraliaOfficialPBAC categories, notices and return routes; pricing/deed categories and application clocks; payment, withdrawal, relief and review; transitional rules. Compilation 1 July 2025 is not a universal new commencement. The standalone independent-review fee inconsistency remains open.2025-07-01Latest observed: 2025-07-08
🇦🇺 AustraliaOfficialApplication and financial-evidence guidance. The July 2023 edition is read with current law and service instructions for routes, review body and refund clocks.2023-07Latest observed: Version 6.0, July 2023
🇦🇺 AustraliaOfficialApproved annual statement: unchanged fees, fee points, estimated service costs and performance measures. Cost estimates are not applicant charges; listing performance measures are not individual approval guarantees.2026-07-01Latest observed: Approved 2026-06-26; published 2026-07-01
🇦🇺 AustraliaOfficialOptional six-year revenue and cost evidence worksheet. Calculated earnings or averages are not statutory thresholds and do not establish a waiver decision.Version date not establishedLatest observed: Current official linked template
🇦🇺 AustraliaOfficialAdministrative guidance for price-disclosure reporting, incentives and calculations. The guide states its information is current at 30 September 2022; use current legislation and the applicable cycle determination for later rules and product prices.2022-09-30Latest observed: 2023-08-14
🇦🇺 AustraliaOfficialBase determination defining the cycle’s disclosed prices and reduction-day schedules. Apply the operative amendments for product-specific conclusions.2026-06-29Latest observed: 2026-06-29
🇦🇺 AustraliaOfficialAmendment effective 4 September 2026 changing the brands and items within the cycle determination.2026-09-03Latest observed: 2026-09-03
🇦🇺 AustraliaOfficialAmendment effective 12 September 2026 adjusting specified disclosed prices in Schedule 1.2026-09-11Latest observed: 2026-09-11
🇦🇺 AustraliaOfficialConfirmed reports distinguish AEMP, pack and dispensing prices, claimed prices and premiums, with separate EFC units.2026-10-01Latest observed: 2026-10-01
🇦🇺 AustraliaOfficialConfirmed reports distinguish AEMP, pack and dispensing prices, claimed prices and premiums, with separate EFC units.2026-10-01Latest observed: 2026-10-01
🇦🇺 AustraliaOfficialPotential savings for non-concessional patients; exclusions and price basis must be considered before an individual estimate.2026-10-01Latest observed: 2026-10-01
🇦🇺 AustraliaOfficialIndicative combination prices for the cycle, subject to the applicable statutory treatment and ministerial decisions.2026-10-01Latest observed: 2026-10-01
🇦🇺 AustraliaOfficialGuidance on direct price-disclosure disputes, supporting evidence and working-day steps; the applicable cycle notice sets the dated deadline.Not establishedLatest observed: 2022-06-08
🇦🇺 AustraliaOfficialMandatory operational standard: specified outpatient expansion, clinician submissions, local DTC boundaries and separate implementation.2026-06Latest observed: 2026-06
🇦🇺 AustraliaOfficialCommencement and selected transitional provisions44–45; not every label or ingredient annex certified.2026-09-30Latest observed: 2026-09-28
🇦🇺 AustraliaOfficialSeparate non-prescription standard and section36 transition; do not apply it as the prescription standard.2026-09-30Latest observed: 2026-09-28
🇦🇺 AustraliaOfficialOfficial announcement and implementation support; legal release-for-supply triggers come from the instruments.2026-09-29Latest observed: 2026-09-29
For education only — not regulatory, pricing or legal advice.